Table 2.
Clinical presentation of hospitalized children with EV-D68.
Clinical presentation | n (%) |
---|---|
Month of presentation (total n = 34) | |
August | 1 (3) |
September | 5 (15) |
October | 25 (74) |
November | 3 (9) |
| |
Parent reported symptoms at presentation (total n = 34) | |
Shortness of breath | 28 (82) |
Cough | 28 (82) |
Rhinorrhea/congestion | 24 (71) |
Fever | 21 (62) |
Wheeze | 15 (44) |
Vomiting | 11 (32) |
| |
Vital signs at presentation (total n = 34) | |
Tachypnea∗ | 27 (79) |
Tachycardia∗ | 20 (59) |
Oxygen saturation <92% | 20 (59) |
Fever ≥ 38°C | 4 (12) |
| |
Auscultatory findings (total n = 34) | |
Decreased air entry | 30 (88) |
Wheeze | 26 (76) |
Crackles | 12 (35) |
Silent chest | 9 (26) |
| |
PRAM score at presentation (total n = 22) | |
0–3 (mild) | 0 (0) |
4–7 (moderate) | 6 (27) |
8–12 (severe) | 16 (73) |
| |
Laboratory findings (total n = 23) | |
Leukocytosis∗∗ | 12 (52) |
Neutrophilia∗∗ | 17 (74) |
Lymphopenia∗∗ | 19 (83) |
| |
Copathogens identified on PCR testing of nasopharyngeal washings (total n = 26) | 11 (42) |
| |
Chest X-ray findings (total n = 29) | |
Normal chest X-ray | 4 (14) |
Minor patchy changes | 6 (21) |
Major patchy changes | 6 (21) |
Lobar changes | 1 (3) |
Peribronchial thickening | 11 (38) |
Hyperinflation | 9 (31) |
∗Vital sign parameters were defined according to norms for age as per the Hospital of Sick Children's Handbook of Pediatrics [15].
∗∗As defined by BCCH's laboratory reference values for age.